Estimating Survival in Patients With Lung Cancer and Brain Metastases

2016651 citationsJournal Articlebronze Open Access

Authors

Paul W. Sperduto · University of Minnesota

Jonathan T. Yang

Kathryn Beal

Hubert Y. Pan · The University of Texas MD Anderson Cancer Center

Paul D. Brown · The University of Texas MD Anderson Cancer Center

Ananta Bangdiwala · University of Minnesota

Ryan Shanley · University of Minnesota

Norman Yeh

Abstract

In recent years, patient survival and physicians' ability to predict survival in NSCLC with brain metastases has improved significantly. The updated Lung-molGPA incorporating gene alteration data into the DS-GPA is a user-friendly tool that may facilitate clinical decision making and appropriate stratification of future clinical trials.

Topics & Keywords

Lung Cancer Treatments and Mutations Brain Metastases and Treatment Lung Cancer Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Oncology

Volume 3, Issue 6, pp. 827-827

DOI: 10.1001/jamaoncol.2016.3834

Field-Weighted Citation Impact: 43.90